4SC AGFRA:VSC Median PS Value is €23.65 as of Jun. 25, 2026, which is 100% below its 10-year median of 1.50. The stock has 7 warning signs investors should review.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. 4SC AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.938. 4SC AG's 10-Year median PS Ratio is 25.2132. Therefore, the Median PS Value for today is €23.65.
As of today (2026-06-25), 4SC AG's share price is €0.10. 4SC AG's Median PS Value is €23.65. Therefore, 4SC AG's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for 4SC AG's Median PS Value or its related term are showing as below:
During the past 13 years, the highest Price to Median PS Value of 4SC AG was 15.53. The lowest was 0.13. And the median was 1.50.
FRA:VSC's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.63 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
4SC AG (FRA:VSC) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
4SC AG's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.10
/
23.65
=
0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4SC AG Median PS Value Related Terms
4SC AG Median PS Value Historical Data
* Premium members only.
The historical data trend for 4SC AG's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:VSC vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, 4SC AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4SC AG Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 4SC AG's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where 4SC AG's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 25.2132.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4SC AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.938.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4SC AG (FRA:VSC) has a Median PS Value of €23.65 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on 4SC AG and its competitors. This is 1477% above median its historical median of 1.50. Over the past decade, 4SC AG's Median PS Value has ranged from 0.13 to 15.53.
Is 4SC AG's Median PS Value too high?
4SC AG's current Median PS Value of €23.65 is 1477% above median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 15.53.
How does 4SC AG's Median PS Value compare to VRTX and REGN?
4SC AG's Median PS Value of €23.65 can be compared against companies in the Biotechnology industry. The industry median Median PS Value is 0.63. Historically, 4SC AG's own Median PS Value has ranged from 0.13 to 15.53 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.63, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on 4SC AG and its competitors. For the Biotechnology industry, the median Median PS Value is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4SC AG's current Median PS Value is €23.65, which is 1477% above median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4SC AG stock overvalued right now?
4SC AG (FRA:VSC) has a current Median PS Value of €23.65. The stock's GF Value™ is €3.51, compared to a current price of €0.10 — trading 97.2% below its estimated fair value. The current Median PS Value is €23.65, which is 1477% above median its 10-year median of 1.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For 4SC AG (FRA:VSC), the current Median PS Value is €23.65 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. The geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VSC has been successfully added to your 